An investigational HIV vaccine routine examined amongst males who’ve intercourse with males (MSM) and transgender folks was protected however didn’t present safety in opposition to HIV acquisition, an unbiased information and security monitoring board (DSMB) has decided. The HPX3002/HVTN 706, or ‘Mosaico,’ Part 3 scientific trial started in 2019 and concerned 3,900 volunteers ages 18 to 60 years in Europe, North America and South America. Based mostly on the DSMB’s suggestion, the examine can be discontinued.
+92 300 859 4219 , +92 300 859 1434 
Cash On Delivery is Available